This page is about the former AIDA research project (2011–2017). It does not describe current activity or endorsement of this independent website.
At a glance
- This is a historical topic page, not an invitation to a current event.
- Older drugs need reliable evidence about benefits and risks.
- Published work and CORDIS provide independently accessible context.
- No archived images or documents have been reproduced.
What did “reviving” mean?
Reviving a medicine does not mean simply reusing an old prescription. It means reassessing how an existing drug performs using modern clinical, microbiological and pharmacological evidence. The former AIDA project was part of this broader research conversation.
A 2015 peer-reviewed paper entitled “Reviving old antibiotics” discusses the challenge of developing evidence for older treatments.
Why it still matters
Antimicrobial resistance can narrow available treatment options. Research on existing antibiotics may help professionals understand where they are useful and where risks or resistance limit their value.
For readers looking for today’s practical information, start with how antibiotic spectrum works and why responsible use matters.
Sources
Original references- PubMed · Reviving old antibiotics
- European Commission CORDIS · AIDA project record (278348)
- European Commission CORDIS · Old antibiotics – a new lease of life
These sources informed this overview. Their organisations do not endorse or review this website.
This page is for general education only. It does not replace advice from a doctor, pharmacist or other qualified healthcare professional. Read our medical disclaimer.